Home › Psoriasis › California › Sacramento
Psoriasis clinical trials in Sacramento, CA
3 studies for Psoriasis are looking for participants at sites in and around Sacramento (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RecruitingPhase 1
- University of California Davis Comprehensive Cancer Center, Sacramento
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
RecruitingPhase 3
- Local Institution - 0077, Sacramento
Use of Total-Body PET to Quantify Systemic and Cutaneous Inflammation in Psoriasis Patients Before and After Intervention With a Nutritionally Balanced Diet
Recruiting
- University of California, Davis - Dermatology Department, Sacramento
About Psoriasis
Psoriasis is a skin disease that causes itchy or sore patches of thick, red skin with silvery scales. Some people also get psoriasis arthritis.
More about Psoriasis on MedlinePlus
Psoriasis trials in other cities
- Trenton, NJ7 studies
- Philadelphia, PA6 studies
- Cleveland, OH6 studies
- Fremont, CA5 studies
- Huntington Beach, CA5 studies
- San Antonio, TX5 studies
- New York City, NY5 studies
- Newton, MA5 studies
- Houston, TX4 studies
- Birmingham, AL4 studies
- Miami, FL3 studies
- Indianapolis, IN3 studies
Other studies in Sacramento
- Non-Small Cell Lung Cancer29 studies
- Lung Cancer23 studies
- Prostate Cancer20 studies
- Breast Cancer19 studies
- Metastatic Cancer17 studies
- Acute Myeloid Leukemia12 studies
- Heart Failure12 studies
- Colon Cancer12 studies
- Cancer (all types)11 studies
- Colorectal Cancer11 studies
- Pancreatic Cancer11 studies
- Bladder Cancer10 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.